American Medical Systems Holdings Inc. and Laserscope, two companies with a significant presence in the urology market, have entered into a definitive merger agreement providing for the acquisition of Laserscope by AMS.
American Medical Systems Holdings Inc. and Laserscope, two companies with a significant presence in the urology market, have entered into a definitive merger agreement providing for the acquisition of Laserscope by AMS. The total acquisition price for Laserscope’s shares and options is approximately $715 million.
The acquisition will add a variety of BPH therapy solutions to AMS’s line of modalities and products for the treatment of pelvic disorders in men and women, according to a statement from the companies.
Investigators assess potential trajectories of women in the urologic work force
June 9th 2023Projections were made under 3 different circumstances: the rate of women entering urology continues to follow logistic growth, there is no further growth of women into urology, and retirement rates among women mirror that of men in urology.
Treatment intensification in advanced prostate cancer: Real-world practice lags behind data
June 9th 2023"It gives me a very rewarding experience…. I see patients with low-grade prostate cancer and when they become advanced prostate cancer, I already have a good relationship with them and don’t have to send them somewhere else," says Abhinav Sidana, MD, MPH.
2 Clarke Drive
Cranbury, NJ 08512